Michael Messinger

Michael Messinger

Vorys, Sater, Seymour and Pease LLP

Contact
View Bio
RSS

Latest Posts › Patent Invalidity

Share:

The Precedent: Federal Circuit Provides Further Clarity on Issues Surrounding Patent Validity in Novartis Pharmaceuticals Corp. v....

In this edition of The Precedent, we outline the validity of a pharmaceutical patent concerning the patent’s written description. Following an appeal from the United States District Court for the District of Delaware, the...more

2/21/2025  /  Intellectual Property Litigation , Obviousness , Patent Infringement , Patent Invalidity , Patent Litigation , Patent Validity , Pharmaceutical Patents , Prior Art
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide